Ironwood Presents Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
https://investor.ironwoodpharma.com/files/doc_news/archive/ac7b20aa-369a-45a6-bfe3-771abd9995dc.pdf
Ironwood Presents Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
https://investor.ironwoodpharma.com/files/doc_news/archive/ac7b20aa-369a-45a6-bfe3-771abd9995dc.pdf
Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
https://investor.ironwoodpharma.com/files/doc_news/archive/6e3a3ef2-a4ff-4508-b89c-612b88f71a4e.pdf
Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
https://investor.ironwoodpharma.com/files/doc_news/archive/6e3a3ef2-a4ff-4508-b89c-612b88f71a4e.pdf
Ironwood and Collaborators Present Preclinical Data Demonstrating that Cyclic GMP Alleviates Intestinal Pain
https://investor.ironwoodpharma.com/files/doc_news/archive/63e9689e-91d0-4cbd-af94-dbe8e8e604c6.pdf
Ironwood and Collaborators Present Preclinical Data Demonstrating that Cyclic GMP Alleviates Intestinal Pain
https://investor.ironwoodpharma.com/files/doc_news/archive/63e9689e-91d0-4cbd-af94-dbe8e8e604c6.pdf
Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
https://investor.ironwoodpharma.com/files/doc_news/archive/041dce91-e5f3-48b2-9056-01078a80dddd.pdf
Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
https://investor.ironwoodpharma.com/files/doc_news/archive/041dce91-e5f3-48b2-9056-01078a80dddd.pdf
Ironwood and Forest to Present Positive Data from Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
https://investor.ironwoodpharma.com/files/doc_news/archive/9f9d25fc-8d2e-470b-9126-8cf0e73f81a0.pdf
Ironwood and Forest to Present Positive Data from Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
https://investor.ironwoodpharma.com/files/doc_news/archive/9f9d25fc-8d2e-470b-9126-8cf0e73f81a0.pdf